Therapeutic approach of patients with IgA nephropathy

Renal Failure

Volumn 26, Issue 2, 2004, Pages 171-177

  Goumenos, Dimitrios S ^a   Brown, Colin B ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

ACE inhibitors; Fish oil; IgA nephropathy; Immunosuppressive drugs; Treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; BONE MARROW SUPPRESSION; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG INDICATION; GLOMERULONEPHRITIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; SQUAMOUS CELL CARCINOMA;

ADRENAL CORTEX HORMONES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; FISH OILS; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3142674838     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120038514     Document Type: Article

References (15)

1. D'Amico, G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy and membranoproliferative glomerulonephritis: survey of the recent literature. Am. J. Kidney Dis. 1992, 20 (4), 315-323.
2. Nolin, L.; Courteau, M. Management of IgA nephropathy: evidence-based recommendations. Kidney Int. 1999, 55 (Suppl. 70), S56-S62.
3. Lai, K.N.; Lai, I.M.; Ho, C.P.; Chan, K.W. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin. Nephrol. 1986, 26 (4), 174-180.
4. Kobayashi, Y.; Hiki, Y.; Kokubo, T.; Horii, A.; Tateno, S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron 1996, 72 (2), 237-242.
5. Pozzi, C.; Bolasco, P.G.; Fogazzi, G.B.; Andrulli, S.; Altieri, P.; Ponticelli, C.; Locatelli, F. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet 1999, 353, 883-887.
6. Locatelli, F.; Del Vecchio, L.; Pozzi, C. The patient with IgA glomerulonephritis - what is the role of steroid treatment? Nephrol. Dial. Transplant. 1999, 14 (5), 1057-1060.
7. Locatelli, F.; Pozzi, C.; Del Vecchio, L.; Andrulli, S.; Pani, A.; Fogazzi, G.; Altieri, P.; Ponticelli, C. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomized multicenter trial. J. Nephrol. 1999, 12 (5), 308-311.
8. Ballardie, F.W.; Roberts, I.S. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J. Am. Soc. Nephrol. 2002, 13 (1), 142-148.
9. Goumenos, D.; Davlouros, P.; El Nahas, A.M.; Ahuja, M.; Shortland, J.R.; Vlachojannis, J.G.; Brown, C.B. Prednisolone and azathioprine in IgA nephropathy? Nephron Clin. Pract. 2003, 93 (2), C58-C68.
10. Pettersson, E.E.; Rekola, S.; Berglund, L.; Sundqvist, K.G.; Angelin, B.; Diczfalusy, U.; Bjorkhem, I.; Bergstom, J. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective double-blind randomized study. Clin. Nephrol. 1994, 41 (4), 183-190.
11. Donadio, J.V. Jr.; Bergstralh, E.J.; Offord, K.P.; Spencer, D.C.; Holley, K.E. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N. Engl. J. Med. 1994, 331 (18), 1194-1199.
12. Dillon, J.J. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J. Am. Soc. Nephrol. 1997, 8 (11), 1739-1744.
13. Donadio, J.V.; Grande, J.R.; Bergstralh, E.J.; Dart, R.A.; Larson, T.S.; Spencer, D.C. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J. Am. Soc. Nephrol. 1999, 10, 1772-1777.
14. Cattran, D.C.; Greenwood, C.; Ritchie, S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am. J. Kidney Dis. 1994, 23 (2), 247-254.
15. Ruggenenti, P.; Perna, A.; Gherardi, G.; Benini, R.; Remuzzi, G. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am. J. Kidney Dis. 2000, 35 (6), 116-1155.